Fresenius Medical Care AG/€FME
1D1W1MYTD1Y5YMAX
About Fresenius Medical Care AG
Fresenius Medical Care, listed under the ticker FME, is a global provider of dialysis services and products for individuals diagnosed with chronic kidney failure. Founded in 1996 and headquartered in Bad Homburg, Germany, the company operates in the healthcare sector. Beyond dialysis, Fresenius Medical Care offers a range of other services, including hospital management and related healthcare services, advancing its position as a comprehensive healthcare provider internationally.
- Ticker
- €FME
- Sector
- Health
- Primary listing
- XETRA
- Employees
- 107,226
- Headquarters
- Bad Homburg, Germany
- Website
- www.freseniusmedicalcare.com
FME Metrics
BasicAdvanced
€11B
12.29
€3.34
0.84
€1.49
3.63%
Price and volume
Market cap
€11B
Beta
0.84
52-week high
€47.84
52-week low
€34.58
Average daily volume
765K
Dividend rate
€1.49
Financial strength
Current ratio
1.071
Quick ratio
0.631
Long term debt to equity
63.838
Total debt to equity
77.75
Dividend payout ratio (TTM)
42.67%
Interest coverage (TTM)
5.20%
Profitability
EBITDA (TTM)
2,689.326
Gross margin (TTM)
26.36%
Net profit margin (TTM)
4.83%
Operating margin (TTM)
10.08%
Effective tax rate (TTM)
20.99%
Revenue per employee (TTM)
€180,000
Management effectiveness
Return on assets (TTM)
3.98%
Return on equity (TTM)
8.52%
Valuation
Price to earnings (TTM)
12.289
Price to revenue (TTM)
0.593
Price to book
0.84
Price to tangible book (TTM)
-5.95
Price to free cash flow (TTM)
6.474
Free cash flow yield (TTM)
15.45%
Free cash flow per share (TTM)
6.348
Dividend yield (TTM)
3.63%
Forward dividend yield
3.63%
Growth
Revenue change (TTM)
-0.46%
Earnings per share change (TTM)
50.07%
3-year revenue growth (CAGR)
-0.33%
10-year revenue growth (CAGR)
2.06%
3-year earnings per share growth (CAGR)
18.11%
10-year earnings per share growth (CAGR)
0.23%
3-year dividend per share growth (CAGR)
9.98%
10-year dividend per share growth (CAGR)
6.65%
What the Analysts think about FME
Analyst ratings (Buy, Hold, Sell) for Fresenius Medical Care AG stock.
FME Financial Performance
Revenues and expenses
FME Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.